In November 2025, the Grand Egyptian Museum (GEM) staged a much-anticipated opening ceremony, marking the culmination of a ...
Acquisition adds YUPELRI®(revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD to Zymeworks' portfolioAcquisition of ...
The AI-based program AlphaFold predicts a protein's 3D structure with remarkable accuracy. However, it tends to reduce heterogeneous structures to a single dominant conformation, or shape, and ...